Eagle Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,824,403
| Closed | -$28.2M | – | 608 |
|
|
2018
Q2 | $28.2M | Buy |
2,824,403
+98,832
| +4% | +$986K | 0.15% | 209 |
|
|
2018
Q1 | $26M | Buy |
2,725,571
+9,404
| +0.3% | +$89.6K | 0.14% | 214 |
|
|
2017
Q4 | $40.3M | Sell |
2,716,167
-327,700
| -11% | -$4.86M | 0.22% | 159 |
|
|
2017
Q3 | $59.6M | Sell |
3,043,867
-481,818
| -14% | -$9.44M | 0.34% | 95 |
|
|
2017
Q2 | $50.7M | Sell |
3,525,685
-24,862
| -0.7% | -$357K | 0.31% | 113 |
|
|
2017
Q1 | $32.7M | Buy |
3,550,547
+51,190
| +1% | +$471K | 0.21% | 155 |
|
|
2016
Q4 | $36.4M | Sell |
3,499,357
-12,807
| -0.4% | -$133K | 0.24% | 133 |
|
|
2016
Q3 | $31.8M | Sell |
3,512,164
-70,897
| -2% | -$642K | 0.22% | 144 |
|
|
2016
Q2 | $26.8M | Sell |
3,583,061
-238,064
| -6% | -$1.78M | 0.19% | 164 |
|
|
2016
Q1 | $34.4M | Sell |
3,821,125
-156,769
| -4% | -$1.41M | 0.24% | 138 |
|
|
2015
Q4 | $51.4M | Buy |
3,977,894
+709,817
| +22% | +$9.17M | 0.34% | 98 |
|
|
2015
Q3 | $31.6M | Buy |
3,268,077
+834,064
| +34% | +$8.06M | 0.22% | 159 |
|
|
2015
Q2 | $25M | Buy |
2,434,013
+1,195,577
| +97% | +$12.3M | 0.14% | 192 |
|
|
2015
Q1 | $13.8M | Buy |
1,238,436
+15,805
| +1% | +$176K | 0.08% | 287 |
|
|
2014
Q4 | $14.2M | Buy |
1,222,631
+783,610
| +178% | +$9.12M | 0.08% | 277 |
|
|
2014
Q3 | $9.72M | Buy |
+439,021
| New | +$9.72M | 0.06% | 327 |
|